About
About YiChang HEC ChangJiang Pharmaceutical Co., Ltd
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. engages in the development, manufacturing, and sale of pharmaceutical products in the therapeutic areas of anti-virus, endocrine and metabolic, and cardiovascular diseases in the People's Republic of China. It manufactures and sells active pharmaceutical ingredients and drugs; researches and develops pharmaceutical products and medical devices, as well as biotechnology; and provides marketing and medical consulting services. The company's product portfolio includes Kewei, Oumeining, Xinhaining, Ertongshu, and Xining. It sells its products to hospitals and medical institutions through a network of distributors. The company was formerly known as Yichang Changjiang Pharmaceutical Company Limited and changed its name to YiChang HEC ChangJiang Pharmaceutical Co., Ltd. in May 2015. The company was incorporated in 2001 and is based in Yichang, China.
Visit company website
5 years, 5 months ago
YiChang HEC ChangJiang Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 5.8% below its 200 day moving average.
From a valuation standpoint, the stock is 98.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.5.
YiChang HEC ChangJiang Pharmaceutical Co., Ltd's total revenue sank by 91.6% to $264M since the same quarter in the previous year.
Its net income has dropped by 76.6% to $222M since the same quarter in the previous year.
Finally, its free cash flow grew by 75.2% to $-324M since the same quarter in the previous year.
Based on the above factors, YiChang HEC ChangJiang Pharmaceutical Co., Ltd gets an overall score of 2/5.